e-learning
resources
European Respiratory Review
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype
Pain, Mallory and Bermudez, Olga and Lacoste, Philippe and Royer, Pierre-Joseph and Botturi, Karine and Tissot, Adrien and Brouard, Sophie and Eickelberg, Oliver and Magnan, Antoine
Source:
Eur Respir Rev 2014; 23: 118-130
Journal Issue:
March
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pain, Mallory and Bermudez, Olga and Lacoste, Philippe and Royer, Pierre-Joseph and Botturi, Karine and Tissot, Adrien and Brouard, Sophie and Eickelberg, Oliver and Magnan, Antoine. Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. Eur Respir Rev 2014; 23: 118-130
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Acute exacerbations of IPF: A neglected threat in IPF ?
Related content which might interest you:
Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Hyperplasia of mucin-secreting epithelial cells: a remodelling feature of airway diseases
Source: Annual Congress 2011 - Mucus in airway diseases: bad or good partner?
Year: 2011
Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition
Source: Eur Respir J 2015; 45: 1258-1272
Year: 2015
Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis.
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Interaction between epithelial cells and sub-epithelial mesenchymal cells in severe non-allergic asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019
Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Mechanical programming of mesenchymal stromal cells to treat lung fibrosis
Source: ERS Lung Science Conference 2018
Year: 2018
Analysis of ciliary beating in reconstituted bronchial epithelium from chronic airway diseases
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Mesenchymal stem cells and fibrotic lung diseases
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021
ST2 on airway bronchial epithelial cell promotes vascular remodelling in the lung
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010
Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis
Source: Eur Respir Monogr 2021; 91: 290-305
Year: 2021
¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Epithelial to mesenchymal transition in basal progenitor epithelial cells cultured from smokers and COPD patients
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Current perspectives in epithelial cell injury and repair: consequences for epithelial functions
Source: Eur Respir Rev 2005; 14: 126-130
Year: 2005
Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Induction of mesenchymal cell phenotypes in lung epithelial cells by adenovirus E1A
Source: Eur Respir J 2006; 28: 1106-1117
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept